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Summary: We have previously shown that peroxisomes are involved in the production and detoxification of
reactive oxygen species and that peroxisomal functions are damaged by such oxygen species. Since nitric
oxide is not only a cellular messenger, but also a free radical, it would be interesting to detect a connection
between nitric oxide levels and peroxisomal enzyme activities. To determine if nitric oxide has an effect on
the activities of peroxisomal functions and whether this effect is based solely on its chemical properties as
reactive oxygen species or its action as a second messenger, effectors of the cellular nitric oxide level were
applied to a cell model (human skin fibroblasts in culture) or directly to the enzymatic assays or both. If
applied to the monolayer at non-cytotoxic concentrations, N-nitro-i-arginine methyl ester hydrochloride, an
inhibitor of nitric oxide synthase (EC 1.14.13.39), increased catalase (EC 1.11.1.6) activity by more than 10%
and decreased the activity of the peroxisomal fatty acid oxidation system by more than 10%. The eifect was
concentration-dependent. Ζ,-Arginine had the contrary effect. Combinations of L-arginine and N-nitro-L-arginine
methyl ester hydrochloride compensated one another. If applied directly to the assays, S-nitroso-N-acetylpenicill-
amine and sodium nitroprusside inhibited catalase activity in a concentration-dependent manner. Sodium nitro-
prusside had no effect on the peroxisomal -oxidation system unless cells were pretreated with N-nitro-L-
arginine methyl ester overnight (50% inhibition).
The results show a differential eifect for the application of nitric oxide-effectors on fibroblast monolayers, cell
suspensions and under assay conditions. Depending on the conditions of the incubation, nitric oxide applied to the
cell monolayer at low doses acts as a second messenger in cells rather than as reactive oxygen species. Under assay
conditions the effect of nitric oxide is more likely that of a reactive oxygen species because it inhibits all measured
enzyme activities.
Introduction blood cells (2, 3); however their size, number and func-
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catalase2) (3). The discovery of enzymes of the glyoxy-
late pathway (6), fatty acid oxidation (6, 7), especially
very long chain fatty acids (8) and enzymes for the syn-
thesis of precursors of plasmalogens (9, 10) underscores
the importance of this organelle in cellular metabolism.
In the last 25 years more than 60 enzymes have been
shown to be present in peroxisomes (3). One of the im-
portant functions of peroxisomes is the metabolism of
reactive oxygen species. The reactive oxygen species
(Of, OH*, H2O2) are normal by-products of cellular
metabolism (11, 13) and levels of these reactive oxygen
species are kept in check by metabolism by the antioxi-
dant enzymes (12). The oxygen consumed in peroxi-
somes is converted to H2O2 and Superoxide (Of), as
suggested by the presence of H2O2 and Of producing
enzymes. An imbalance in activities in the synthesis and
degradation in ischaemia-reperfiision (14, 15, 16) and in
animals treated with sublethal doses of lipopolysaccha-
ride (17) and peroxisomal proliferators (18, 19) are
known to cause oxidative stress in peroxisomes. Re-
cently several authors have investigated the damaging
effect of reactive oxygen species with respect to peroxi-
somal functions (20, 21). Both catalase and the oxida-
tion of very long chain fatty acids were shown to be
inhibited by reactive oxygen species (20, 21).
Nitric oxide is a short lived inorganic free radical gas
of the formula *N = O. In mammalian cells it is pro-
duced from L-arginine by oxidation of a guanidino nitro-
gen by nitric oxide synthase2) yielding L-citrulline as
a co-product (22—25). In mammalian cells nitric oxide
synthase exists in 3 isoforms (24) and is active in its
homodimeric form. Two of the isoforms are generally
constitutive and their activity depends on elevated levels
of Ca2+. The third isoform is inducible and the activity
'is generally independent of elevated levels of Ca2+. Nit-
ric oxide has numerous functions, mediating physiologi-
cal processes in many organs such as neuroprotection
(26) by regulating various enzyme activities (24, 27, 28)
and during pathophysiological conditions by its cyto-
toxic effects (26-32). The effects of nitric oxide are
mediated by peroxynitrite, produced by the reaction of
nitric oxide with Of (29, 30). Nitric oxide affects the
DNA synthesis in cultured human skin fibroblasts (33).
Fibroblasts contain inducible nitric oxide synthase and
produce nitric oxide (22, 23, 34, 35). Both the presence
of nitric oxide synthase and the described effects of nit-
ric oxide in fibroblasts make it an interesting model sys-
tem for investigations of regulatory effects of nitric ox-
ide on cellular and organelle level.
2) Enzymes:
Catalase, hydrogen peroxide : hydrogen-peroxide oxidoreductase
(EC 1.11.1.6)
Nitric oxide synthase, L-arginine, NADPH : oxygen oxidoreduc-
tase (nitric oxide forming) (EC 1.14.13.39)
We examined the effect of compounds that inhibit the
synthesis of nitric oxide or produce nitric oxide on the
peroxisomal function of human skin fibroblasts and de-
scribe for the first time that peroxisomal enzyme activi-
ties are regulated by nitric oxide.
Materials and Methods
Cell lines (fibroblasts) and tissue culture conditions
Control fibroblast cell lines were derived from healthy subjects.
All cells were used in passages 10-16. Fibroblasts were grown
in Dulbecco's Modified Eagle medium (Gibco/BRL; Paisley, UK)
supplemented with 150 ml/1 bovine calf serum (Gibco/BRL; Pais-
ley, UK) and gentamycin (50 mg/1) under isobaric conditions (5%
CO2, air). Cells were harvested by trypsinisation.
Protein assay
Protein was estimated by the method of Bradford using bovine
serum albumin as a standard (36).
Catalase assay
Catalase enzyme activity was measured as described previously
(37, 38).
Oxidation of [l-1 4D]phytanic acid
Assays were performed on cell suspensions of trypsinized, unbro-
ken fibroblasts from control cell lines under isotonic conditions.
The oxidation of phytanic acid to pristanic acid was determined as
[14C]O2 release from l-[14C]phytanic acid. The reaction was initi-
ated with 100-200 μg protein (fibroblast suspension) and stopped
with H2SO4 (4 mol/1). The [14C]CO2 was collection in KOH-wetted
cotton by shaking the reaction tubes overnight (39, 40).
Oxidation of [l-14C]lignoceric acid
Assays were performed on cell suspensions of trypsinized, unbro-
ken fibroblasts from control cell lines under isotonic conditions.
[l-14C]Lignoceric acid (2 GBq/mol, 0.403 MBoJ was suspended in
4 ml of a solution of a-cyclodextrin (20 g/1) in isotonic buffer (0.25
mol/1 sucrose, 3 mmol/1 imidazole, pH = 7.2, 1 mmol/1 EDTA,
1 nil/1 ethanol) by sonication. The reaction was initiated by the
addition of [l-14C]lignoceric acid (2.52 kBq) to fibroblasts (100-
150 μg protein) suspended in 200 μΐ isotonic buffer. The tubes
were incubated for 30 minutes or l h at 37 °C in a shaking
waterbath. The reaction was stopped by the addition of KOH in
methanol followed by incubation at 60 °C in a shaking waterbath.
The amount of radioactivity in the upper phase of the Folch parti-
tion represents the rate of oxidation of lignoceric acid (8, 38).
Treatment with effectors
Direct nitric oxide application was performed with S-nitroso-N-
acetylpenicillamine, a nitric oxide producing compound (41),
which was dissolved in ethanol. This solution was added to fibro-
blast monolayers, cell suspensions or assays to give the concentra-
tions indicated. N-Nitro-L-arginine methyl ester hydrpchloride
(Biomol; Hamburg, Germany), L-arginine, jD-arginirie and sodium
nitroprusside (sodium pentacyanonitrosylferrate(III), Sodium
Nitroferricyanide, SIGMA, Vienna, Austria) were prepared as
stock solutions in fresh Hank's balanced salt solution (Gibco/BRL;
Paisley, UK) immediately before application to assays, cell mono-
layers cor suspensions to yield the concentrations indicated.
The following types of application of effectors were performed:
Eur J Clin Chem Clin Biochem 1995; 33 (No 11)
Kremser et al.: NO and peroxisomes 765
Treatment l
The effectors were N-nitro-Z,-arginine methyl ester (1 mmol/1), L-
arginine and Z)-arginine (10 mmol/1). The concentrations are final
concentrations in tissue culture media. A single dose was applied
to fibroblast monolayers 20 hours before performing the assays
(activity of catalase and oxidation of lignoceric acid, fig. la and b).
Treatment 2
Test of the concentration dependence under tissue culture condi-
tions
The effectors used (given concentrations are those in tissue culture
media) were N-nitro-L-arginine methyl ester (1,2, 5 and 7 mmol/1),
Ζ,-arginine (10 mmol/l, 20 mmol/1) and combinations of N-nitro-Z-
arginine methyl ester and Z-arginine (1 mmol/1 N-nitro-Z-arginine
methyl ester/10 mmol/1 Z-arginine and 2 mmol/1 N-nitro-Z-arginine
methyl ester/20 mmol/1 L-arginine). A single dose was applied to
monolayers 20 hours before performing the assays (activity of cata-
lase, oxidation of lignoceric acid and phytanic acid, fig. 2a, b, c).
Treatment 3
Pretreatment (24 hours) of cell monolayers was performed with 20
mmol/1 I-arginine (fig. 3c,f) or 2 mmol/1 N-nitro-Z-arginine
methyl ester (fig. 3b, e) followed by the addition of effectors to the
assays (S-nitroso-N-acetylpenicillarnine, ethanol as control for the
addition of S-nitroso-N-acetylpenicillamine, sodium nitroprusside,
N-nitro-Z-arginine methyl ester, all 2 mmol/1 and 20 mmol/1 Ζ,-argi-
nine) to distinguish between the effect of nitric oxide on enzymes
in intact cells and enzyme systems under assay conditions (fig.
3a-f).
Treatment 4
Concentration dependence of catalase-inhibition by nitric oxide
Stock solutions of S-nitrose-N-acetylpenicillamine in ethanol and
sodium nitroprusside in fresh Hank's balanced salt solution were
applied directly to the assays to give concentrations ranging from
0.02 mmol/1 to 2 mmol/1 (fig. 4a and b).
Treatment 5
Direct application of nitric oxide-donor stock solutions or ethanol
(to give 2 mmol/1 sodium nitroprusside, 2 mmol/i S-nitroso-N-ace-
tylpenicillamine or ethanol blank) to monolayers and suspended
intact cells. Monolayers were incubated with effectors for 16 hours
(fig. 5a and b, 16 hours) and untreated cells suspended in complete
tissue culture media were incubated with effectors for 1 hour (fig.
5a and b, 1 hour) in a shaking waterbath (37 °C) to distinguish
between short term and long term effect of nitric oxide on whole
cells. Cells were washed twice with fresh Hank's balanced salt
solution to remove the effectors before assays (fig. 5a and b).
Statistics
Statistical comparisons were made using the analysis of variance
followed by Student's Mest; n = 6, unless other values are given.
The expression 'significant' is used for p < 0.05.
Results and Discussion
Treatment 1
(inhibition and activation of the synthesis
of nitric oxide)
The first step in determining whether a cellular process
depends on nitric oxide or nitric oxide synthase activity
is to apply specific inhibitors of nitric oxide synthase to
decrease the intracellular nitric oxide level. N-Nitro-Z,-
arginine methyl ester, one of the best known inhibitors
of nitric oxide synthase (23), was used to reduce the
cellular nitric oxide synthesis rate. Ζ,-Arginine was ap-
plied to induce cellular nitric oxide synthesis, thus ele-
vating the intracellular nitric oxide level. D-Arginine
served as a blank for Ζ,-arginine because it is not con-
verted to nitric oxide by nitric oxide synthase and thus
has no effect on the synthesis rate and intracellular level
of nitric oxide (fig. 1 and 2). N-Nitro-L-arginine methyl
ester was applied at a concentration of 1 mmol/1. The
concentrations of Ζ,-arginine and jD-arginine, respec-
tively, alone or in combination with N-nitro-L-arginine
methyl ester were 10 mmol/1. N-Nitro-Z,-arginine methyl
ester, Ζ,-arginine and Z)-arginine were added to mono-
layers 20 hours before harvesting the cells (fig. la
and b). The rate of the oxidation of lignoceric acid was
determined in cell suspension as described in the meth-
ods section. Following the treatment of fibroblast mono-
layers with the nitric oxide synthase inhibitor N-nitro-Z,-
arginine methyl ester, catalase activity is more than 10%
higher than control values (n = 6, p < 0.01), (fig. la).
Z)-Arginine has no effect, as expected, since it is not a
suitable substrate for nitric oxide synthase and Z,-argi-
nine inhibits catalase activity and compensates the effect
of N-nitro-Z,-arginine methyl ester (fig. 1 a). The oxida-
tion of lignoceric acid is significantly affected by both
N-nitro-L-arginine methyl ester (n = 5, p < 0.05) and Ζ,-
arginine (n = 5, p < 0.05). Effector doses, which en-
hance catalase activity, decrease lignoceric acid oxida-
tion activity and vice versa (fig. Ib). Under tissue cul-
ture conditions catalase and the very long chain fatty
acid oxidation system (peroxisomal -oxidation system)
are affected by nitric oxide in an opposite way, probably
due to differential regulation of these enzyme systems
by nitric oxide or peroxynitrite.
Treatment 2
(concentration dependence of effects under
cell culture conditions)
To examine the concentration dependence of N-nitro-Z,-
arginine methyl ester and/or Ζ,-arginine, different con-
centrations of the effectors N-nitro-L-arginine methyl es-
ter, Ζ,-arginine or both were added to the cells in culture
(fig. 2a—c). The increase of the activity of catalase is
still significant (n = 6, p < 0.01 for 1 mmol/1 and
2 mmol/1 N-nitro-Z,-arginine methyl ester), but does not
fully follow the concentration profile of N-nitro-Z,-argi-
nine methyl ester (fig. 2a). At higher concentrations of
N-nitro-Zr-arginine methyl ester (5 and 7 mmol/1) the el-
evation of catalase activity becomes insignificant. On
the other hand, both Ζ,-arginine and combinations of N-
nitro-L-arginine methyl ester and Ζ,-arginine at both con-
centrations decrease catalase activity (fig. 2a). The
decrease caused by 20 mmol/1 Ζ,-arginine is more pro-
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nounced that that of 10 mmol/1Ζ,-arginine which reflects
the concentration dependence.
The inhibition of the oxidation of lignoceric acid (fig.
2b) and phytanic acid (fig. 2c) by N-nitro-Z-arginine
methyl ester is concentration-dependent (contrary to the
activation of catalase activity), so that the lower the con-
centration of nitric oxide, the lower the activity of the
oxidation of lignoceric and phytanic acids. Combined
application of 1 mmol/1 N-nitro-I-arginine methyl ester
and 10 mmol/11-arginine strongly inhibits (as is the case
for the activity of catalase as shown in fig. 2a) instead
of compensating the effects. Combined with 2 mmol/1
N-nitro-I-arginine methyl ester, 20 mmol/1 L-arginine
has almost no effect. I-Arginine (10 mmol/1) stimulates
both the activity of the oxidation of lignoceric and phy-
tanic acids. L-Arginine (20 mmol/1) gives the same result
as in combination with 2 mmol/1 N-nitro-L-arginine
methyl ester. Application of the nitric oxide synthase-
inhibitor N-nitro-I-arginine methyl ester has an influ-
ence on the activity of peroxisomal enzyme systems:
Catalase activity is enhanced, the oxidations of very
long chain fatty acids and phytanic acid are inhibited.
The effects are mainly concentration dependent. 1-Argi-
nine decreases catalase activity and increases the activity
of the peroxisomal a- and -oxidation systems.
Treatment 3
(combination of overnight treatment and
addition of effectors to the assays)
This set of incubations (fig. 3) was similar to the above
mentioned experiments except for the following differ-
ences: Cell monolayers of human skin fibroblasts were
incubated with N-nitro-L-arginine methyl ester or I-ar-
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ginine for 24 hours (= pre-treatment) at higher concen-
trations than in treatment 1 (2 mmol/1 and 20 mmol/1,
respectively). Cells (pre-treated cells and untreated con-
trols) were then harvested according to the procedure
described in the methods section (low centrifugal force,
no sucrose or imidazole, suspension of cells in Hank's
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Fig. 2 Treatment 2: Activities of catalase (a), oxidation of lignoc-
eric acid (b) and phytanic acid (c) after incubation of cell mono-
layers for 20 hours with a single dose of N-nitro-L-arginine methyl
ester (L-NAME, 1, 2, 5 and 7 mrnol/ΐχ L-arginine (L-arg, 10
mmol/1 and 20 mmol/1) and combinations of N-nitro-£-arginine
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and L-NAME, 2 mmol/1/L-arg, 20 mmol/1).
Eur J Clin Chem Clin Biochem 1995; 33 (No 11)
768 Kremser et al.: NO and peroxisomes
3-
c
'φΕ 2Q.
I
D
•5 1
3
SNAP Ethanol L-NAME Nitroprusside L-Arg None
.£
2
o
Q.
O)
3
(D
"<D 1
•M '(0
U
SNAP Ethanol L-NAME Nitroprusside L-Arg None
c
'φ
S
Q.
σ>
3
•i 1
•M
(ΟΟ
ϊ
ί
-1- 1 j.
SNAP Ethanol L-NAME Nitroprusside L-Arg None
Fig. 3 Treatment 3: Pre-treatment of cell monolayers for 24 hours
with L-arginine (c and f, L-arg, 20 mmol/1) or N-nitro-L-arginine
methyl ester (b and e, L-NAME, 2 mmol/1) followed by the addi-
tion of S-nitroso-N-acetylpenicillamine (SNAP, 2 mmol/1), ethanol
as a control for the addition of S-nitroso-N-acetylpenicillamine,
sodium nitroprusside (2 mmol/1), N-nitro-I-arginine methyl ester
(L-NAME, 2 mmol/1) and L-arginine (L-arg, 20 mmol/1) to the as-
says.
a) Activity of catalase without pre-treatment of monolayers but
addition of effectors to the assay.
b) Activity of catalase after pretreatment of the monolayer with N-
nitro-L-arginine methyl ester (L-NAME) followed by addition of
effectors to the assay.
c) Activity of catalase after pretreatment of the monolayer with Z-
arginine (L-arg) followed by addition of effectors to the assay.
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Fig. 3 Continued
d) Activity of the peroxisomal -oxidation without pre-treatment f) Activity of the peroxisomal -oxidation after pretreatment of the
of monolayers but addition of effectors to the assay. monolayer with L-arginine (L-arg) followed by addition of efFec-
e) Activity of the peroxisomal -oxidation after pretreatment of the tors to the assay,
monolayer with N-nitro-L-arginine methyl ester (L-NAME) fol-
lowed by addition of effectors to the assay.
Eur J Clin Chem Clin Biochem 1995; 33 (No 11)
770 Kremser et al.: NO and peroxisomes
balanced salt solution) and incubated with effectors un-
der assay conditions. The reaction of lignoceric acid oxi-
dation, performed in suspensions of intact cells, was ini-
tiated by changing the temperature from 4 to 37 °C, not
by addition of sample to the reaction mixture or sub-
strate to the reaction mixture (see methods). Thus nitric
oxide producing substances could be added immediately
before the start of the reaction. Likewise, for the catalase
assay, samples were not incubated with nitric oxide syn-
thase/nitric oxide modulators prior to the assay. Nitric
oxide synthase/nitric oxide modulators were added im-
mediately before the start of the reaction.
Cell monolayers were incubated overnight with X-argi-
nine (20 mmol/1, fig. 3c and f) or N-nitro-I-arginine
methyl ester (2 mmol/1, fig. 3b and e). Cells without pre-
treatment served as controls for the effect of the incub-
ations performed under assay conditions (fig. 3a and d).
Treated and untreated cells were harvested and, under
assay conditions for catalase and oxidation of lignoceric
acid, incubated with substances influencing nitric oxide
metabolism (N-nitro-L-arginine methyl ester and L-argi-
nine, fig. 3 a—f) or nitric oxide producing chemicals (S-
nitroso-N-acetylpenicillamine and sodium nitroprusside,
fig. 3a-f). S-Nitroso-N-acetylpenicillamine and sodium
nitroprusside spontaneously release nitric oxide when
solubilized. S-Nitroso-N-acetylpenicillamine is not solu-
ble in aqueous solutions, therefore samples (fig. 3a—f)
containing the same volume of ethanol which was used
for solubilizing the appropriate amount of S-nitroso-N-
acetylpenicillamine were used as controls. Since the oxi-
dation of lignoceric acid is carried out at isotonic condi-
tions with intact suspended cells, S-nitroso-N-acetyl-
penicillamine could not be used as nitric oxide donor
since the high ethanol concentration (5 ml/1) necessary
for its solubilisation makes the determination of the oxi-
dation rate of lignoceric acid impossible under our assay
conditions. Sodium nitroprusside also spontaneously re-
leases nitric oxide in solution (aqueous solutions, neutral
pH) at ambient light. Therefore solutions have to be kept
in the dark until the start of the reaction. In figures 3a—e
'None' means no addition of nitric oxide modulators to
the assay to show the effect of the pre-treatment for 24
hours with N-nitro-I-arginine methyl ester and L-argi-
nine. In all three pre-treatments (fig. 3a—c) the pattern
of the activity changes of catalase, as a response to the
effectors added under assay conditions, is very similar
except for the absolute specific activities which depend
on the pre-treatment. In all cases catalase activity is se-
verely inhibited by direct addition of nitric oxide releas-
ing drugs (sodium nitroprusside and S-nitroso-N-ace-
tylpenicillamine) to the assay. Since the reaction temper-
ature for the catalase assays is close to 0 °C, it was ex-
pected that N-nitro-I-arginine methyl ester (which
inhibits nitric oxide synthesis) and Ζ,-arginine (which has
to be converted to citrulline to yield nitric oxide via the
nitric oxide synthase pathway) would not show a large
effect and their direct effect, if any at all, would be much
less pronounced than that of the nitric oxide releasing
chemicals (S-nitroso-N-acetylpenicillamine and sodium
nitroprusside). Addition of 2 mmol/1 nitroprusside to the
assay completely inhibits catalase'activity. S-Nitroso-N-
acetylpenicillamine at the same concentration has less
effect but still significantly inhibits catalase activity. The
effect of ethanol is negligible but, due to a very low
solubility of S-nitroso-N-acetylpeniculamine under as-
say conditions, the nitric oxide release of S-nitroso-N-
acetylpenicillamine is also decreased.
On addition of effectors under assay conditions the oxi-
dation of lignoceric acid is inhibited in all cases, con-
trary to the results of the overnight incubation with ef-
fectors. This can be explained by the inhibition of cata-
lase by Ζ,-arginine (fig. la and 2b) and nitroprusside un-
der assay conditions (fig. 3a—c and 4a), which causes
higher levels of hydrogen peroxide in peroxisomes and
thus inhibits the oxidation of lignoceric acid (42), which
under test conditions by itself produces higher hydrogen
peroxide amounts than in cell culture. N-Nitro-L-argi-
nine methyl ester inhibits the rate of oxidation of lignoc-
eric acid, both at application to the monolayers (fig. 2b)
and after pre-treatment also under assay conditions (fig.
3e and f). Incubation with N-nitro-i-arginine methyl es-
ter for 20 hours results in significantly increased oxida-
tion rates of lignoceric acid (p < 0.001, n = 5, fig. 3e
compared to 3d, none) which can be caused by newly
synthesized enzyme protein for the peroxisomal -oxi-
dation, probably acyl CoA-oxidase, the rate limiting en-
zyme for the oxidation of very long chain fatty acids,
which after depletion of endogenous very long chain
fatty acids causes a virtually higher turnover of labeled
exogenous substrate under assay conditions. Thus, con-
trary to the pre-treatment with Ζ,-arginine, pre-treatment
with N-nitro-Z-arginine methyl ester enhances the effect
of modulators applied to the cell suspension assays:
Even the inhibiting effect of N-nitro-Z,-arginine methyl
ester added under assay conditions is significant
(p < 0.05, n = 5, fig. 3e, L-NAME). All agents lower
the activity of the oxidation of lignoceric acid (fig. 3e)
as is the case after pre-treatment with Ζ,-arginine (3d
and f). Since this significant decrease is only seen after
24 hours pre-treatment with N-nitro-Z,-arginine methyl
ester, longer decrease (for 1 day versus 20 hours) of the
intracellular nitric oxide level induces the peroxisomal
-oxidation system. The advantage of our cell suspen-
sion assay lies in its close reflection of physiological
conditions, because we are operating with a complete
and intact suspended cellular system. On the other hand
it also reflects the activities of many processes, not only
the peroxisomal fatty acid oxidation system, which can
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be activated/inhibited at more than one position. It also
monitors the uptake of the fatty acid through the cellular
membrane, the intracellular transport of the fatty acid
and is influenced by intracellular pools of very long
chain fatty acids.
Treatment 4
(dose dependence of direct catalase inhibi t ion
by nitric oxide)
The inhibition of catalase activity by nitric oxide is dose
dependent (fig. 4a andb, dose response curves for S-
nitrose-N-acetylpenicillamine and sodium nitroprus-
side). The inhibition curves are different. The reason for
the difference is the low solubility of S-nitroso-N-ace-
tylpenicillamine in aqueous solutions and the limited de-
composition on solubilisation. Concentrations which are
without effect if applied to monolayers inhibit more than
nine tenths of the catalase activity (see treatment 5, 1
hour).
Treatment 5
(comparison of short and long term effect of
nitric oxide)
To distinguish between short term (1 hour) and long
term (16 hours) effects of nitric oxide on viable cells,
cell monolayers were given a one time dose of sodium
nitroprusside, S-nitroso-N-acetylpenicillamine or etha-
nol 16 hours before assays were performed (long term
effect, fig. 5a and b, left panels, 16 hours). Sodium nitro-
prusside, S-nitroso-N-acetylpenicillamine and/or ethanol
were added to the suspensions of untreated cells in com-
plete media for one hour prior to the assays (fig. 5a
andb, right panels, 1 hour) to monitor the short term
effect of nitric oxide. Before performing the assays, cells
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Fig. 4 Treatment 4, dose-response. Different concentrations of sodium nitroprusside (a) and
S-nitroso-N-acetylpenicillamine (b) were applied directly to the catalase assays.
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were washed twice with Hank's balanced salt solution
to remove effectors. Addition of sodium nitroprusside or
S-nitroso-N-acetylpenicillamine to the cell monolayer
16 hours prior to the assays does not alter the oxidation
rate of lignoceric acid (fig. 5b, left panel, Nitroprusside
16 hours). Sodium nitroprusside, added to the cells for
one hour (fig. 5b, right panel, Nitroprusside 1 hour), sig-
nificantly enhances the activity of lignoceric acid oxida-
tion (p < 0.05, n = 5). Catalase activity is significantly
decreased (p < 0.01, n = 6) after overnight addition of
sodium nitroprusside (fig. 5a left panel, Nitroprusside 16
hours) and increased after 1 hour of incubation with so-
dium nitroprusside (fig. 5a, right panel, Nitroprusside 1
hour). S-Nitroso-N-acetylpenicillamine does not influ-
ence the activity, probably because of its poor solubility
or rate of release of nitric oxide in culture media (fig.
5a, SNAP 16 hours and SNAP 1 hour).
Neither sodium nitroprusside nor S-nitroso-N-acetyl-
penicillamine (2 mmol/1), applied to cells either in cul-
ture or cell suspension, show the effect of direct applica-
tion to the assays (fig. 3). This shoves that direct applica-
tion of nitric oxide produces different effects with re-
spect to peroxisomal enzyme activities in total cells and
under assay conditions.
Conclusion
Peroxisomal enzyme activities are regulated by nitric
oxide. Under assay conditions the mechanism probably
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involves a decrease in catalase activity mediated by
the free radical *N = or its reaction product with
Superoxide, peroxynitrite, causing oxidative damage
(29, 30). The decrease in catalase activity is followed
by higher levels of hydrogen peroxide within the per-
oxisomes (13). Hydrogen peroxide is known to inhibit
the peroxisomal ß-oxidation (42). Under tissue culture
conditions increased nitric oxide synthesis also
decreases catalase activity but enhances the activity of
the peroxisomal ß-oxidation. This effect can not be
explained with higher levels of hydrogen peroxide,
since reactive oxygen species inhibit both catalase (43,
44) and peroxisomal ß-oxidation (14—16, 21), but de-
monstrates the action of nitric oxide as a second mes-
senger on cellular level.
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